Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publication date: 2024

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publication Year: 2024

Authors & Co-authors:  Hoffman Risa M RM Brummel Sean S Ziemba Lauren L Chinula Lameck L McCarthy Katie K Fairlie Lee L Jean-Philippe Patrick P Chakhtoura Nahida N Johnston Ben B Krotje Chelsea C

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.

Journal: Lancet (London, England)

Publication date: 2022

Journal: Lancet (London, England)

Publication Year: 2022

Authors & Co-authors:  Delany-Moretlwe Hughes Bock Ouma Hunidzarira Kalonji Kayange Makhema Mandima Mathew